Results 31 to 40 of about 13,918 (210)

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET) - Extended Long-Term Outcomes.

open access: yesInternational Journal of Radiation Oncology, Biology, Physics, 2022
BACKGROUND Long-term randomized data assessing the impact of ablative therapies in patients with oligometastases is lacking. The BLINDED-FOR-REVIEW randomized phase II trial was originally designed with 5 years of follow-up, but the trial was amended in ...
S. Harrow   +21 more
semanticscholar   +1 more source

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

open access: yesmedRxiv, 2020
Purpose: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data testing this paradigm are
D. Palma   +23 more
semanticscholar   +1 more source

IMMUNE EFFECTS OF STEREOTACTIC ABLATIVE RADIATION THERAPY IN PATIENTS WITH MALIGNANT TUMORS: LITERATURE REVIEW

open access: yesСибирский онкологический журнал, 2020
The purpose of the study was to conduct a systematic analysis of the data available in the modern literature on the systemic (abscopal) effects in radiation therapy, which are mediated by immunological phenomena.Material and Methods.A structured search ...
A. Yu. Zozulya   +2 more
doaj   +1 more source

Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis

open access: yesRadiation Oncology, 2021
Background The purpose of this study was to compare the treatment efficacy and safety of re-irradiation (re-RT) using stereotactic ablative radiotherapy (SABR) and initial SABR for primary, recurrent lung cancer or metastatic lung tumor.
Tae Hoon Lee   +4 more
doaj   +1 more source

Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care

open access: yesCurrent Oncology, 2021
Background: Recent clinical trial results reported that stereotactic radiotherapy (SABR) may improve survival for patients with oligometastatic (OM) cancer. Given that these results come from a phase II trial, there remains considerable uncertainty about
Adam J. N. Raymakers   +3 more
doaj   +1 more source

Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study

open access: yesRadiation Oncology, 2021
Background Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging assessment of response after SABR is difficult.
Dae-Myoung Yang   +12 more
doaj   +1 more source

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy

open access: yesRadiation Oncology, 2020
Background Stereotactic Ablative Radiotherapy (SABR) is an effective treatment that improves local control for many tumours. However, the role of SABR in gynecological cancers (GYN) has not been well-established.
E. Leung   +14 more
doaj   +1 more source

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease

open access: yesFrontiers in Oncology, 2021
BackgroundIn certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative ...
Dirk Mehrens   +11 more
doaj   +1 more source

SABR: A Stable Adaptive Bitrate Framework Using Behavior Cloning Pretraining and Reinforcement Learning Fine-Tuning [PDF]

open access: yesIEEE Wireless Communications and Networking Conference
With the advent of 5G, the internet has entered a new video-centric era. From short-video platforms like TikTok to long-video platforms like Bilibili, online video services are reshaping user consumption habits.
Peng-Cheng Luo   +5 more
semanticscholar   +1 more source

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

open access: yesAdvances in Radiation Oncology, 2021
Purpose: Oligoprogression, defined as limited sites of progression on systemic therapy, in patients with metastatic renal cell carcinoma (mRCC) is not uncommon, possibly because of inter- and intratumoral heterogeneity.
Jonathan E. Schoenhals, BS   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy